Skip to main content
Premium Trial:

Request an Annual Quote

Florida Upholds Orchid Cellmark Contract

NEW YORK (GenomeWeb News) – Orchid Cellmark said today that the Florida Department of Revenue has upheld a contract that had been awarded to the firm to conduct all publicly funded paternity testing for the State of Florida.
 
The Princeton, NJ-based firm said that the contract had been awarded late last year but was held up by protest of the award by Laboratory Corporation of America, which formerly had provided paternity testing to the state. An administrative law judge oversaw a three-day trial in April, and the Department of Revenue’s decision is based on the findings from those proceedings, said Orchid.
 
The multi-year contract begins Sept. 1 and is extendable for an additional three years beyond its expiration in 2011. Orchid President and CEO Thomas Bologna said in a statement that the contract is worth approximately $1.2 million per year.
 
Orchid noted that it previously provided the State of Florida with roughly one-third of its paternity testing services, while LabCorp had serviced the remaining two-thirds of the state.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.